Yahoo Finance

GNT Pharma Receives Regulatory Approval to Initiate Multinational Phase 3 Clinical Trials for its Breakthrough Stroke Therapy ' Nelonemdaz™ '

NEW YORK, July 24, 2025 /PRNewswire/ -- GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, today announced its IND Application to commence Global Phase 3 ...
Yahoo Finance

GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)

Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of target ...
Medindia

GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz

** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Multinational Phase 3 Clinical Trial protocols ...
Food

GNT Group expands EXBERRY colors range with 'greater intensity' reds

GNT Group's new line of EXBERRY food colors includes more intense shades of red, including 'vivid red', 'purple plum', 'veggie red', and 'brilliant pink' made from fruits and vegetables such as ...
Business Wire

GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

YONGIN, South Korea--(BUSINESS WIRE)--GNT Pharma Inc. today reports positive top-line results from a phase II, double-blind, randomized, placebo-controlled, multi-center study assessing the safety and ...
Food

GNT opens venture arm to invest in sustainability across supply chain

Natural plant-based color company GNT’s venture arm will invest in pre-seed and seed startups in 2025 to spearhead its 2030 sustainability agenda. The recently launched GNT Ventures professionalizes ...